Segra International’s Strategic Acquisition: Enhancing Cannabis Genetics and Cultivation

In a significant development in the cannabis industry, Segra International, a leader in cannabis agriculture technology based in Vancouver, British Columbia, has announced its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery located in Kelowna, BC. This merger aims to strengthen Segra’s leadership in the realm of cannabis tissue culture and pathogen testing, pivotal for meeting the escalating global demand for clean, true-to-type cannabis clones.

Leveraging Existing Infrastructure for Growth

The integration of Klonetics’ established licenses and infrastructure will allow Segra to substantially expand its nursery capacity and operational capabilities. Segra’s state-of-the-art tissue culture and molecular laboratories will be enhanced by this acquisition. Furthermore, the flowering capacity offered by Klonetics will facilitate dedicated research and development, cultivar characterization, and performance validation of new cannabis genetics.

Commitment to Quality and Diversity

Through the merger with Klonetics, Segra aims to significantly elevate the quality and diversity of cannabis genetics available to clients, ranging from small boutique growers to large-scale producers. This collaboration will ensure that all customers have access to superior cultivars deeply aligned with market demands, thus enabling them to maximize yields and optimize cultivation practices.

Facility Upgrades for Immediate Operational Readiness

To prepare for this ambitious expansion, Segra is currently initiating facility upgrades to guarantee immediate operational readiness. With the enhanced capacity, Segra is set to consistently deliver clean, pathogen-tested, and genetically authentic cannabis plants and premium flowers to markets both in Canada and internationally.

Leadership Insights

Jamie Blundell, the CEO of Segra International, shared his enthusiasm regarding the amalgamation, stating, “The amalgamation with Klonetics marks an important milestone in our growth. By combining Klonetics’ facility with Segra’s advanced tissue culture, genetics, and global sales force, we are well-positioned to accelerate our growth and service to the global cannabis industry.”

Strategic Vision and Commitment

This strategic alignment not only emphasizes Segra’s commitment to innovation, operational excellence, and superior plant quality but also reinforces its role as a trusted partner for cannabis cultivators and producers around the globe. The merger stands as a testament to Segra’s ongoing efforts to enhance the overall quality and efficiency of cannabis cultivation.

About Segra International

Segra International is a pioneering entity specializing in various aspects of cannabis agriculture, including tissue culture, DNA fingerprinting, pathogen detection services, and flower brokering. With proprietary technologies, the company empowers clients to enhance financial performance and mitigate disease risks, all while optimizing their cultivation practices. Operating industrial-scale laboratories, Segra produces Verified Segra Stock™ cannabis plantlets in collaboration with leading breeders and ships them to licensed producers both within Canada and globally.

The company prides itself on its world-class team of specialists in agronomy, molecular biology, genetics, plant tissue culture, cultivation, and regulatory compliance, further supporting Segra’s visionary approach to cannabis cultivation.

Contact Information

To learn more about Segra International and its innovative offerings, please reach out via email at [email protected] or visit our website at Segra International.